General MedicationsORALStandard

ELTROMBOPAG OLAMINE

Standard Dose

EQ 25MG ACID/PACKET

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview ELTROMBOPAG OLAMINE is listed in Drugs@FDA under application 216620 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ELTROMBOPAG OLAMINE Form and strength FOR SUSPENSION;ORAL - EQ 25MG ACID/PACKET Sponsor ANNORA PHARMA Submission history Latest submission status date: 2024-04-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview ELTROMBOPAG OLAMINE is listed in Drugs@FDA under application 216620 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ELTROMBOPAG OLAMINE Form and strength FOR SUSPENSION;ORAL - EQ 25MG ACID/PACKET Sponsor ANNORA PHARMA Submission history Latest submission status date: 2024-04-18 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.